Associated Papers
Targeting PCSK9 to tackle cardiovascular disease.
Hummelgaard S et al.
Pharmacology & Therapeutics, 2023
[Monogenic hypercholesterolemias: new genes, new drug targets].
Mandel'shtam MIu et al.
Genetika, 2008
Molecular biology of PCSK9: its role in LDL metabolism.
Horton JD et al.
Trends in Biochemical Sciences, 2007
A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol.
Kotowski IK et al.
American Journal of Human Genetics, 2006
Select a paper to view details